Inventor
DUBE SUSHANT OMPRAKASH
IN17 patents
⚠️ This page may combine multiple inventors who share the name “DUBE SUSHANT OMPRAKASH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SLAYBACK PHARMA LLC
14 patentsUS11590122B2Feb 28, 2023
Pharmaceutical compositions of cabozantinib
SLAYBACK PHARMA LLC14 citations92
US11679105B1Jun 20, 2023
Pharmaceutical compositions of cabozantinib
SLAYBACK PHARMA LLC11 citations83
US12213972B2Feb 4, 2025
Stable pharmaceutical compositions of apixaban
SLAYBACK PHARMA LLC2 citations71
US12138255B2Nov 12, 2024
Pharmaceutical compositions of cabozantinib
SLAYBACK PHARMA LLC2 citations71
US11484518B1Nov 1, 2022
Stable oral suspensions of baclofen
SLAYBACK PHARMA LLC2 citations71
US11696906B2Jul 11, 2023
Stable oral suspensions of baclofen
SLAYBACK PHARMA LLC0 citations60
US11564898B1Jan 31, 2023
Stable oral suspensions of baclofen
SLAYBACK PHARMA LLC0 citations60
US12521383B2Jan 13, 2026
Stable pharmaceutical compositions of apixaban
SLAYBACK PHARMA LLC0 citations59
US11957685B2Apr 16, 2024
Pharmaceutical compositions of tofacitinib for oral administration
SLAYBACK PHARMA LLC0 citations58
US11766438B2Sep 26, 2023
Pharmaceutical compositions of tofacitinib for oral administration
SLAYBACK PHARMA LLC0 citations58
US12491178B2Dec 9, 2025
Stable pharmaceutical compositions of edaravone
SLAYBACK PHARMA LLC0 citations56
US12343330B2Jul 1, 2025
Stable pharmaceutical compositions of edaravone
SLAYBACK PHARMA LLC0 citations56
US10952981B2Mar 23, 2021
Liquid pharmaceutical compositions of baclofen for oral administration
SLAYBACK PHARMA LLC0 citations52
US12194028B2Jan 14, 2025
Stable pharmaceutical compositions of apixaban
SLAYBACK PHARMA LLC0 citations50